FDG-PET in a myocardial tuberculoma

Braquet, P.; Baptista, Grégory; Ilonca, D.; Roubille, François; Moing, Vincent Le; Jeandel, Claude

doi:10.1093/ageing/afu147

Cited by 3 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Visual diagnostic tools, especially FDG-PET/CT, magnetic resonance imaging (MRI) and echocardiogram can provide guidance in the work-up of an intracardial mass [12], [13], [14]. However, only biopsy for histopathological examination and, most importantly, mycobacterial culture can confirm the TB diagnosis and exclude other differential diagnoses.…”

Section: Discussionmentioning

confidence: 99%

Diagnostic challenges in a patient with myocardial tuberculoma: A case report

Säll

Cha

Holmberg

2016

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Diagnostic challenges in a patient with myocardial tuberculoma: A case report

Säll

Cha

Holmberg

2016

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

show abstract

“…Literature has reported cases of myocardial tuberculoma and TB myocarditis. 105,106 Because of the physiologic myocardial uptake of 18 F-FDG, proper preparation of patient is important Figure 8 TB peritonitis showing uniform thickened peritoneum with intense 18 F-FDG uptake. 18 F-FDG uptake noted in multiple areas of the abdomen.…”

Section: Tb Of the Myocardiummentioning

confidence: 99%

Tuberculosis

Ankrah

Glaudemans

Maes

et al. 2018

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

Tuberculosis (TB) is currently the world's leading cause of infectious mortality. Imaging plays an important role in the management of this disease. The complex immune response of the human body to Mycobacterium tuberculosis results in a wide array of clinical manifestations, making clinical and radiological diagnosis challenging. F-FDG-PET/CT is very sensitive in the early detection of TB in most parts of the body; however, the lack of specificity is a major limitation.F-FDG-PET/CT images the whole body and provides a pre-therapeutic metabolic map of the infection, enabling clinicians to accurately assess the burden of disease. It enables the most appropriate site of biopsy to be selected, stages the infection, and detects disease in previously unknown sites. F-FDG-PET/CT has recently been shown to be able to identify a subset of patients with latent TB infection who have subclinical disease. Lung inflammation as detected byF-FDG-PET/CT has shown promising signs that it may be a useful predictor of progression from latent to active infection. A number of studies have identified imaging features that might improve the specificity of F-FDG-PET/CT at some sites of extrapulmonary TB. Other PET tracers have also been investigated for their use in TB, with some promising results. The potential role and future perspectives of PET/CT in imaging TB is considered. Literature abounds on the very important role ofF-FDG-PET/CT in assessing therapy response in TB. The use of F-FDG for monitoring response to treatment is addressed in a separate review.

show abstract